Nipocalimab Clinical Trials (2026): 20 Studies for Healthy & Myasthenia Gravis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
20 Nipocalimab clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 13 indications (including Healthy & Myasthenia Gravis) and 2,773 total planned enrollment. 7 Phase 3 Nipocalimab trials and 6 Phase 2 are listed. 8 Nipocalimab clinical trials are actively recruiting at 100 U.S. sites across 28 states. Most recent activity: NCT07438496 (Nov 2031).
Where to Participate: All Nipocalimab Trial Sites in the U.S. (100 sites across 28 states)
Every actively recruiting Nipocalimabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | The University of Alabama at Birmingham | Birmingham35205 | NCT06533098 | Map |
| AZ | Neuromuscular Research Center and Clinic | Paradise Valley85028 | NCT04951622 | Map |
| AZ | Phoenix Children's Hospital | Phoenix85016 | NCT05265273 | Map |
| CA | David S Hallegua MD A Professional Corporation | Beverly Hills90211 | NCT07438496 | Map |
| CA | Neurology Center of North Orange County | Fullerton92835 | NCT07217587 | Map |
| CA | Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis | Hemet92543 | NCT07438496 | Map |
| CA | University of California at San Diego | La Jolla92037 | NCT05912517 | Map |
| CA | Advanced Medical Research | La Palma90623 | NCT07438496 | Map |
| CA | Childrens Hospital Los Angeles | Los Angeles90027 | NCT05265273 | Map |
| CA | Kaiser Permanente Los Angeles Medical Center | Los Angeles90027 | NCT05912517 | Map |
| CA | Lucile Packard Children's Hospital Stanford | Palo Alto94304 | NCT05265273 | Map |
| CA | Care Access Research | Pasadena91101 | NCT04951622 | Map |
| CA | The Neurology Group | Pomona91767 | NCT07217587 | Map |
| CA | UC Davis School of Medicine | Sacramento95817 | NCT05912517 | Map |
| CA | UC Davis School of Medicine | Sacramento95817 | NCT06533098 | Map |
| CA | UCSF Benioff Children's Hospital | San Francisco94158 | NCT05265273 | Map |
| CA | Solace Clinical Research California | Tustin92780 | NCT07438496 | Map |
| CA | Inland Rheumatology Clinical Trials Inc. | Upland91786 | NCT07438496 | Map |
| CO | Children's Hospital Colorado | Aurora80045 | NCT05265273 | Map |
| CO | Childrens Hospital Colorado | Aurora80045 | NCT05912517 | Map |
| CO | Childrens Hospital Colorado | Aurora80045 | NCT06533098 | Map |
| CO | University of Colorado Anschutz Medical Campus | Aurora80045 | NCT04951622 | Map |
| CO | IMMUNOe Health and Research Centers | Centennial80112 | NCT05327114 | Map |
| CO | Advanced Neurology of Colorado | Fort Collins80528 | NCT07217587 | Map |
| CT | University of Connecticut | Farmington06030 | NCT07217587 | Map |
| CT | Yale New Haven Hospital | New Haven06519 | NCT04951622 | Map |
| FL | Arthritis & Rheumatic Disease Specialties | Aventura33180 | NCT07438496 | Map |
| FL | FM Clinical Research, LLC South Florida Neurology Associates, P. A. | Boca Raton33487 | NCT04951622 | Map |
| FL | SFM Clinical Research LLC | Boca Raton33487 | NCT07217587 | Map |
| FL | Clinical Research of West Florida 1 | Clearwater33765 | NCT07438496 | Map |
| FL | Healthcare Innovations Institute Inc | Coral Springs33067 | NCT05327114 | Map |
| FL | Avanti Clinical Research Corp | Hialeah33013 | NCT07438496 | Map |
| FL | LeJenue Research Associates PLLC | Miami33126 | NCT07438496 | Map |
| FL | University of Miami | Miami33136 | NCT05912517 | Map |
| FL | Pro-Care Research Center, Corp. | Miami Gardens33014 | NCT07438496 | Map |
| FL | Floridian Clinical Research LLC | Miami Lakes33016 | NCT07438496 | Map |
| FL | Medsol Clinical Research Center Inc | Port Charlotte33952 | NCT04951622 | Map |
| FL | Clinical Research of West Florida | Tampa33606 | NCT07438496 | Map |
| FL | University of South Florida | Tampa33612 | NCT04951622 | Map |
| FL | University of South Florida Morsani Center for Advanced Healthcare | Tampa33613 | NCT05265273 | Map |
| GA | Atlanta Research Center for Rheumatology | Marietta30060 | NCT07438496 | Map |
| IL | HSHS St. Elizabeth's Hospital | O'Fallon62269 | NCT07217587 | Map |
| IL | Advocate Children's Hospital | Park Ridge60068 | NCT05912517 | Map |
| IL | Advocate Children's Hospital | Park Ridge60068 | NCT06533098 | Map |
| IL | Willow Rheumatology and Wellness PLLC | Willowbrook60527 | NCT07438496 | Map |
| IN | Josephson Wallack Munshower Neurology, PC | Indianapolis46256 | NCT07217587 | Map |
| IN | Riley Children s Hospital | Indianapolis46202 | NCT05912517 | Map |
| IA | University of Iowa Hospital and Clinics | Iowa City52242 | NCT06533098 | Map |
| KS | University of Kansas Medical Center | Kansas City66160 | NCT04951622 | Map |
| KS | University of Kansas Medical Center | Kansas City66160 | NCT05327114 | Map |
| KY | University of Kentucky Medical Center | Lexington40536 | NCT05912517 | Map |
| LA | Accurate Clinical Research, Inc. | Lake Charles70605 | NCT07438496 | Map |
| MD | Johns Hopkins Hospital | Baltimore21287 | NCT05327114 | Map |
| MD | Johns Hopkins Hospital | Baltimore21287 | NCT05912517 | Map |
| MI | C.S. Mott Children's Hospital | Ann Arbor48109 | NCT05265273 | Map |
| MI | Henry Ford Hospital | Detroit48202 | NCT07217587 | Map |
| MI | Revive Research Institute | Sterling Heights48313 | NCT07438496 | Map |
| MN | Midwest Fetal Care Center | Minneapolis55404 | NCT05912517 | Map |
| MO | Kansas City Veterans Affairs Medical Center | Kansas City64128 | NCT05327114 | Map |
| NY | Columbia University Medical Center | New York10032 | NCT05912517 | Map |
| NY | South Shore Neurologic Associates - Patchogue | Patchogue11772 | NCT05327114 | Map |
| NY | University of Rochester Medical Center | Rochester14642 | NCT06533098 | Map |
| NC | University of North Carolina (UNC) - School of Medicine | Chapel Hill27599-7516 | NCT05912517 | Map |
| NC | University of North Carolina at Chapel Hill | Chapel Hill27599 | NCT06533098 | Map |
| NC | DJL Clinical Research, PLLC | Charlotte28211 | NCT07438496 | Map |
| NC | Joint and Muscle Research Institute | Charlotte28204 | NCT07438496 | Map |
| NC | The Neurological Institute, PA | Charlotte28204 | NCT05327114 | Map |
| NC | Duke University School of Medicine | Durham27710 | NCT04951622 | Map |
| NC | Cross Creek Medical Clinic | Fayetteville28304 4422 | NCT07438496 | Map |
| NC | Velocity Clinical Research, Inc. | Raleigh27607 6010 | NCT07217587 | Map |
| NC | Atrium Health Wake Forest Baptist | Winston-Salem27157 | NCT07217587 | Map |
| OH | University of Cincinnati | Cincinnati45267 | NCT05912517 | Map |
| OH | University of Cincinnati | Cincinnati45267 | NCT06533098 | Map |
| OH | Cleveland Clinic | Cleveland44145 | NCT04951622 | Map |
| OH | Cleveland Clinic Main Campus | Cleveland44195 | NCT05327114 | Map |
| OH | Paramount Medical Research & Consulting | Middleburg Heights44130 | NCT07438496 | Map |
| OR | Oregon Health and Science University | Portland97239 | NCT05912517 | Map |
| OR | Oregon Health And Science University | Portland97239 | NCT06533098 | Map |
| PA | Lehigh Valley Hospital | Allentown18103-6218 | NCT05912517 | Map |
| PA | Penn State Milton S Hershey Medical Ctr | Hershey17033 | NCT05265273 | Map |
| PA | Childrens Hospital Of Philadelphia | Philadelphia19106 | NCT05265273 | Map |
| PA | Clinical Research Philadelphia | Philadelphia19114 | NCT07438496 | Map |
| PA | Hospital of the University of Pennsylvania | Philadelphia19104 | NCT06533098 | Map |
| SC | Medical University of South Carolina | Charleston29425 | NCT04951622 | Map |
| TN | West Tennessee Research Institute | Jackson38305 | NCT07438496 | Map |
| TX | Arthritis and Rheumatology Research Institute | Allen75013 | NCT07438496 | Map |
| TX | Amarillo Center for Clinical Research | Amarillo79124 | NCT07438496 | Map |
| TX | Austin Neuromuscular Center | Austin78756 | NCT05327114 | Map |
| TX | University of Texas Dell Medical School Department of Women's Health | Austin78723 | NCT05912517 | Map |
| TX | Texas Neurology | Dallas75206 | NCT07217587 | Map |
| TX | University of Texas Medical Branch | Galveston77555 | NCT06533098 | Map |
| TX | University Of Texas Medical Branch At Galveston | Galveston77555 | NCT05912517 | Map |
| TX | R and H Clinical Research | Katy77449 | NCT07438496 | Map |
| TX | Southwest Rheumatology Research LLC | Mesquite75150 | NCT07438496 | Map |
| TX | Texas Rheumatology Research Institute LLC | Plano75024 | NCT07438496 | Map |
| TX | Epic Medical Research 1 | Red Oak75154 | NCT07438496 | Map |
| TX | Fort Bend Rheumatology Associates PLLC | Sugar Land77479 | NCT07438496 | Map |
| UT | University of Utah | Salt Lake City84108 | NCT06533098 | Map |
| VA | Macon & Joan Brock Virginia Health Sciences at Old Dominion University | Norfolk23507 | NCT05912517 | Map |
| WI | Advocate Health - Aurora St. Luke's Medical Center | Milwaukee53215 | NCT05327114 | Map |
Nipocalimab clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | withdrawn | temporarily not available | Total |
|---|---|---|---|---|---|---|
| P1 | 4 | 4 | ||||
| P2 | 1 | 4 | 1 | 6 | ||
| P2/P3 | 2 | 2 | ||||
| P3 | 6 | 1 | 7 | |||
| N/A | 1 | 1 |
Recruiting Nipocalimab clinical trials (8)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07438496 | GARDENIAA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | P3 | Lupus Erythematosus, Systemic | 600 | Mar 2026 |
| NCT06533098 | FREESIA-3A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | P3 | Thrombocytopenia, Neonatal Alloimmune | 50 | Feb 2025 |
| NCT06449651 | FREESIA-1A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | P3 | Thrombocytopenia, Neonatal Alloimmune | 39 | Nov 2024 |
| NCT05912517 | AZALEAA Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) | P3 | Hemolytic Disease of the Fetus and Newborn | 120 | Dec 2023 |
| NCT07217587 | EPICComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis | P3 | Myasthenia Gravis | 115 | Jan 2026 |
| NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | P2/P3 | Myasthenia Gravis | 12 | Jul 2022 |
| NCT05327114 | CIDPEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | P2/P3 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 201 | Sep 2022 |
| NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | P3 | Myasthenia Gravis | 199 | Jul 2021 |
Nipocalimab clinical trials by indication
Healthy (4)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05827874 | — | P1 | completed | A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants |
| NCT05151692 | — | P1 | completed | A Study of JNJ-80202135 in Healthy Chinese Adult Participants |
| NCT04973566 | — | P1 | completed | A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants |
| NCT04848558 | — | P1 | completed | A Study of Nipocalimab in Healthy Male and Female Participants |
Myasthenia Gravis (3)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07217587 | EPIC | P3 | recruiting | Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis |
| NCT05265273 | — | P2/P3 | recruiting | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis |
| NCT04951622 | — | P3 | recruiting | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis |
Thrombocytopenia, Neonatal Alloimmune (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06533098 | FREESIA-3 | P3 | recruiting | A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) |
| NCT06449651 | FREESIA-1 | P3 | recruiting | A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) |
Arthritis, Rheumatoid (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06028438 | DAISY | P2 | completed | A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis |
| NCT04991753 | — | P2 | completed | A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis |
Lupus Erythematosus, Systemic (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07438496 | GARDENIA | P3 | recruiting | A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus |
Lupus Nephritis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04883619 | — | P2 | withdrawn | A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis |
Sjogrens Syndrome (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06741969 | DAFFODIL | P3 | active not recruiting | Nipocalimab in Moderate to Severe Sjogren's Disease |
Hemolytic Disease of the Fetus and Newborn (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05912517 | AZALEA | P3 | recruiting | A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05327114 | CIDP | P2/P3 | recruiting | Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Myositis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05379634 | SPIREA | P2 | active not recruiting | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies |
Sjogren's Syndrome (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04968912 | — | P2 | completed | A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) |
Systemic Lupus Erythematosus (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04882878 | — | P2 | completed | A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus |
Warm Autoimmune Hemolytic Anemia (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05221619 | — | N/A | temporarily not available | Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) |
Nipocalimab pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| GARDENIA | NCT07438496 | P3 | recruiting | Lupus Erythematosus, Systemic | 600 | — |
| FREESIA-3 | NCT06533098 | P3 | recruiting | Thrombocytopenia, Neonatal Alloimmune | 50 | — |
| FREESIA-1 | NCT06449651 | P3 | recruiting | Thrombocytopenia, Neonatal Alloimmune | 39 | — |
| AZALEA | NCT05912517 | P3 | recruiting | Hemolytic Disease of the Fetus and Newborn | 120 | — |
| EPIC | NCT07217587 | P3 | recruiting | Myasthenia Gravis | 115 | — |
| DAFFODIL | NCT06741969 | P3 | active not recruiting | Sjogrens Syndrome | 655 | — |
| SPIREA | NCT05379634 | P2 | active not recruiting | Myositis | 36 | — |
| DAISY | NCT06028438 | P2 | completed | Arthritis, Rheumatoid | 103 | — |
Terminated and withdrawn Nipocalimab trials (1)
Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.
- NCT04883619withdrawnA Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
All Nipocalimab trials (20)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07438496 | GARDENIA | A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | P3 | recruiting | 600 | Janssen Research & Development, LLC | Mar 2026 |
| NCT06533098 | FREESIA-3 | A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | P3 | recruiting | 50 | Janssen Research & Development, LLC | Feb 2025 |
| NCT06449651 | FREESIA-1 | A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | P3 | recruiting | 39 | Janssen Research & Development, LLC | Nov 2024 |
| NCT05912517 | AZALEA | A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) | P3 | recruiting | 120 | Janssen Research & Development, LLC | Dec 2023 |
| NCT07217587 | EPIC | Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis | P3 | recruiting | 115 | Janssen Research & Development, LLC | Jan 2026 |
| NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | P2/P3 | recruiting | 12 | Janssen Research & Development, LLC | Jul 2022 | |
| NCT05327114 | CIDP | Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | P2/P3 | recruiting | 201 | Janssen Research & Development, LLC | Sep 2022 |
| NCT06741969 | DAFFODIL | Nipocalimab in Moderate to Severe Sjogren's Disease | P3 | active not recruiting | 655 | Janssen Research & Development, LLC | Dec 2024 |
| NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | P3 | recruiting | 199 | Janssen Research & Development, LLC | Jul 2021 | |
| NCT04883619 | A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis | P2 | withdrawn | 0 | Janssen Research & Development, LLC | Jan 2026 | |
| NCT05379634 | SPIREA | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies | P2 | active not recruiting | 36 | Janssen Research & Development, LLC | Jul 2022 |
| NCT04882878 | A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus | P2 | completed | 228 | Janssen Research & Development, LLC | Aug 2021 | |
| NCT06028438 | DAISY | A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis | P2 | completed | 103 | Janssen Research & Development, LLC | Aug 2023 |
| NCT04968912 | A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) | P2 | completed | 163 | Janssen Research & Development, LLC | Sep 2021 | |
| NCT05827874 | A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants | P1 | completed | 32 | Janssen Research & Development, LLC | Apr 2023 | |
| NCT05151692 | A Study of JNJ-80202135 in Healthy Chinese Adult Participants | P1 | completed | 30 | Janssen Research & Development, LLC | May 2022 | |
| NCT04991753 | A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis | P2 | completed | 53 | Janssen Research & Development, LLC | Oct 2021 | |
| NCT04973566 | A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants | P1 | completed | 48 | Janssen Research & Development, LLC | Aug 2021 | |
| NCT04848558 | A Study of Nipocalimab in Healthy Male and Female Participants | P1 | completed | 89 | Janssen Research & Development, LLC | May 2021 | |
| NCT05221619 | Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) | — | temporarily not available | 0 | Janssen Research & Development, LLC | — |
Nipocalimab clinical trials: frequently asked questions
- How many Nipocalimab clinical trials are there?
- 20 Nipocalimab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 8 are actively recruiting participants. 8 are marked completed.
- Are Nipocalimab clinical trials recruiting in 2026?
- Yes — 8 Nipocalimab trials are actively recruiting in 2026, with 100 U.S. sites across 28 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Nipocalimab being studied for?
- Nipocalimab is being studied for Healthy, Myasthenia Gravis, Thrombocytopenia, Neonatal Alloimmune, Arthritis, Rheumatoid, Myositis and 8 more. The trials are grouped by indication on this page.
- What phase is Nipocalimab in?
- Nipocalimab clinical trials span 7 Phase 3, 6 Phase 2, 4 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Nipocalimab clinical trials?
- The lead sponsor across the most Nipocalimab trials is Janssen Research & Development, LLC. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Nipocalimabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: